Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet Effects of Standardized Tomato Extract in Hypertension
NCT03206944Phase 4Completed
- Start
- Jul 2015
- Primary completion
- Jan 2017
01
Overview
Phase 4, randomised, open-label trial (2 arms). Primary endpoint: Inhibition of platelet function in response to anti-platelet therapy at 1 month. Started Jul 2015; status: completed.
Beyond the preview
Go deeper on NCT03206944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03206944.